A Study to See How Safe a New Medicine (NNC6022-0004) is in Healthy People and People Living With Obesity

Clinical trial NCT07693868 · RECRUITING

Trial details

NCT number: NCT07693868
Sponsor: Novo Nordisk A/S
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Obesity Elevated High-sensitivity C-reactive Protein (hsCRP)

Start date: 2026-07-06
Primary completion: 2027-08-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.